Prasugrel versus Clopidogrel in Patients with Acute Coronary SyndromesStephen D. Wiviott, Elliott M. Antman, Eugene Braunwald et al.|New England Journal of Medicine|2007Cited by 6.7k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-UpBehnood Bikdeli, Gregory Y.H. Lip, Mahesh V. Madhavan et al.|Journal of the American College of Cardiology|2020Cited by 2.9k
Rivaroxaban in Patients with a Recent Acute Coronary SyndromeJessica L. Mega, C. Michael Gibson, Eugene Braunwald et al.|New England Journal of Medicine|2011Cited by 1.9k
Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trialGilles Montalescot, Elliott M. Antman, Stephen D. Wiviott et al.|The Lancet|2009Cited by 1.1k
Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J. Connolly, Truman J. Milling, Mark Crowther et al.|New England Journal of Medicine|2019Cited by 945